VRNG Recent activities 08/17/2014 02:25:35 $VRNG Are you

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
VRNG Recent activities 08/17/2014 02:25:35 $VRNG
Are you saying you didn't KNOW what business they're in?
You thought maybe it was a condom company?
Oh, that's right, another lawsuit! This company is nothing more than a patient infringenent Case Mill. The only people making money on this stock are the lawyers! Lord knows we'll NEVER see a penny of *the cash*!
AGREE! .025-.55
Lose... not loose...
So how many shares do you have SHORT, cause this is obviously going alot lower
Thanks for confirming A.R. from operations is ZERO, because, there are NO product or service offerings. No revenue is being GENERATED, hence, A.R. is ZERO!
I said the cash is from lawsuit settlements, in my last post. But, you are missing the point. This company has ZERO revenue from normal operations. And, they even stated that the loss of the search patent appeal would cripple them.

$21M IN REVENUE LOSS, and, the only money they have is from lawsuit settlements. The company even stated in their annual report that CASH BURN is high from ALL the companies they are SUING. $13M in LEGAL expenses!

Then, on top of ALL that, they are claiming $65M in GOODWILL asset. Goodwill from what, all the lawsuits? They have NO revenues from product or service offerings. That ASSET is OVERstated.

This company needs to be AUDITED. IMO


You'll have to be MORE specific. You see, I know every number I have provided is correct, because, I pulled every number from the 10q. You, on the other hand, are making blanket statements. So, it is your burden to disprove anything I have stated. I welcome your reply. ; )
Well said. RD is such a troll.
epic
The money from settlements talked about in the 10Q is from other litigation that they have successfully settled recently (ie: ADT/Tyco) NOT Google money. Also in the past they received $1 million from MSFT along with patents. Neither of which will be returned. You would know this if you followed this stock more than just the past 2 days.

VRNG was never entitled to actually collect a penny from GOOG until appeals were final. Therefore no potential GOOG awards were ever factored into the financial reports. You can't report money that you never received. Please stop clogging the board with your nonsense.
Yes the operative word was but now ZTE is the new prize.
THIS COMPANY'S LIFE WAS BASED ON WINNING THOSE LAWSUIT'S I EXPECT THIS WILL KEEP FALLING. OMG OUCH
Your right it is a matter of Public Record. But you are making statements that are not backed up in the 10q. I suggest you read it again and state facts only--Good Luck!
...that's what she said.
It is a matter of public record. Check the 10Q. It s ALL in there. Per the 10q, their cash on hand consists of lawsuit settlements. Everything that I have posted was pulled directly from the 10q.
That's the ugliest candle I've ever seen in my life
Got bunch on friday.Lets see how it goes on Monday
The ruling Friday was obviously a huge disappointment and for me a surprise but I found this link that at least offers a glimmer of hope at three options Vringo has in there case against Google. While probably a long shot, at least there is a chance that this case can be turned around and hold
Google liable for Infringement.

Link can be found here: http://m.managingip.com/Article.aspx?ArticleId=3371638
Scroll down for more posts ▼

Top 10 Most Recent News Articles

NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 5

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 6

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 9

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 8

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 3

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 3

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Bryan Leon Joins Storm Properties to Elevate Acquisitions Team

Updated Category News Views 381

Storm Properties Welcomes Bryan Leon as New Hire Storm Properties Inc., recognized as a significant player in the development, ownership, and management of a variety of properties, is delighted to announce the addition of Bryan Leon to their team as Land Acquisitions Manager. This appointment comes as part of the company's ongoing strategy to strengthen its position in...

Continue Reading
Revolutionizing Trade Setups with Innovative Scanner Technology

Updated Category News Views 280

Revolutionizing Trade Setups with Innovative Scanner Technology Stock Market Guides is thrilled to introduce significant advancements to its cutting-edge stock scanner technology. The latest update empowers users by showcasing the historical track record of various trade setups it identifies, offering unparalleled insight to traders looking to enhance their market...

Continue Reading
EQT Life Sciences Champions $39 Million Investment in Aerska

Updated Category News Views 101

EQT Life Sciences Champions $39 Million Investment in Aerska Advancing RNA Therapeutics EQT Life Sciences has recently announced a significant milestone: leading a $39 million Series A financing round in Aerska. This funding will be instrumental in pushing forward Aerska’s innovative brain shuttle technology. Designed to optimize the delivery of RNA interference...

Continue Reading
NVIDIA's Anticipated Earnings Report: Key Insights for Investors

Updated Category News Views 160

Understanding NVIDIA's Upcoming Earnings Announcement NVIDIA (NASDAQ: NVDA) is set to release its much-anticipated quarterly earnings report soon. Investors are keen to understand how the company is performing and what guidance it will provide for future quarters. Analysts predict that NVIDIA will announce an earnings per share (EPS) of $0.98, which indicates the level of...

Continue Reading
Innovative Partnership Forged for Enhanced Vehicle Safety

Updated Category News Views 185

Innovative Partnership Forged for Enhanced Vehicle Safety NOVOSENSE Microelectronics, a key player in the semiconductor industry known for its high-performance analog and mixed-signal chips, is joining hands with Continental Automotive Technologies to enhance vehicle safety systems. This collaboration aims to push the envelope in developing automotive-grade sensors that...

Continue Reading